Cargando…
The distribution of blood eosinophil levels in a Japanese COPD clinical trial database and in the rest of the world
BACKGROUND: Blood eosinophil measurements may help to guide physicians on the use of inhaled corticosteroids (ICS) for patients with chronic obstructive pulmonary disease (COPD). Emerging data suggest that COPD patients with higher blood eosinophil counts may be at higher risk of exacerbations and m...
Autores principales: | Barnes, Neil, Ishii, Takeo, Hizawa, Nobuyuki, Midwinter, Dawn, James, Mark, Hilton, Emma, Jones, Paul W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799851/ https://www.ncbi.nlm.nih.gov/pubmed/29440882 http://dx.doi.org/10.2147/COPD.S144108 |
Ejemplares similares
-
LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes
por: Hizawa, Nobuyuki
Publicado: (2015) -
A comprehensive assessment using COPD assessment test scoring and modified Medical Research Council dyspnea scoring is necessary for personalized therapy for COPD patients
por: Teramoto, Shinji, et al.
Publicado: (2015) -
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016) -
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018) -
Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)